TickerFacts.

Company research / MMM

3M Co (MMM)

Build a valuation ↗↓ Download CSV

SEC name 3M CO · CIK 0000066740 · NYSE · Surgical & Medical Instruments & Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Dec 31

For the year ended 2025-12-31, 3M Co reported revenue of $24.95B. Revenue grew 1.5% from the prior annual period. Over the twelve months to 2026-09-30, revenue was $25.25B.

Key ratios (year ended 2025-12-31)

39.9%
Gross margin (computed)
18.6%
Operating margin
13.0%
Net margin
68.5%
Return on year-end equity
1.5%
Revenue growth (YoY)

Computed by TickerFacts from revenue minus cost of revenue. This may differ from the issuer's reported gross profit or margin; check the revenue and cost definitions.

Beyond the statements

Follow the company.

Explore new filings, reported insider transactions and company relationships.

Open company research ↗

Latest selected filing: Form 8-K (current report) · 2026-10-19

Headquarters locality: Maplewood · View on map

Annual financials

Annual flows and balances are grouped by their actual period end. Select a figure to open its SEC filing. n/a means a matching observation is unavailable. Free cash flow is operating cash flow minus capital expenditures, and EBITDA is operating income plus depreciation and amortization, for the same period, computed by TickerFacts.

The first column covers the twelve months to 2026-09-30 from the latest quarterly report: flows are the last fiscal year plus this year to date minus the same months a year earlier, and balances are as of that date. Per-share figures are annual only.

Period endedTTM to
2026-09-30		2025-12-312024-12-312023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-31
Revenue$25.25B$24.95B$24.57B$24.61B$26.16B$35.35B$32.18B$32.14B$32.77B$31.66B$30.11B
Cost of Revenue$15.27B$14.99B$14.45B$14.98B$15.85B$18.80B$16.61B$17.14B$16.68B$16.05B$15.12B
Gross Profit (computed)$9.98B$9.96B$10.13B$9.63B$10.31B$16.56B$15.58B$15.00B$16.08B$15.60B$14.99B
R&D Expensen/an/a$700.00M$700.00M$800.00M$1.20B$1.10B$1.25B$1.25B$1.35B$1.25B
Operating Income$4.74B$4.63B$4.82B-$10.69B$4.37B$7.37B$7.16B$6.17B$7.21B$7.69B$7.03B
Depreciation & Amortization$1.43B$1.31B$1.36B$1.99B$1.83B$1.92B$1.91B$1.59B$1.49B$1.54B$1.47B
EBITDA$6.16B$5.94B$6.18B-$8.70B$6.20B$9.28B$9.07B$7.77B$8.70B$9.24B$8.50B
Net Income$3.54B$3.25B$4.17B-$7.00B$5.78B$5.92B$5.45B$4.52B$5.35B$4.86B$5.05B
EPS (Diluted)n/a$6.00$7.55-$12.63$10.18$10.12$9.36$7.72$8.89$7.93$8.16
Total Assets$39.53B$37.73B$39.87B$50.58B$46.45B$47.07B$47.34B$44.66B$36.50B$37.99B$32.91B
Total Liabilities$34.39B$32.99B$35.97B$45.71B$31.68B$31.95B$34.41B$34.53B$26.65B$26.36B$22.56B
Long-Term Debt$14.99B$12.60B$13.04B$14.24B$15.94B$17.35B$18.78B$19.36B$14.16B$13.20B$11.48B
Shareholders' Equity$4.17B$4.75B$3.89B$4.87B$14.77B$15.12B$12.93B$10.13B$9.85B$11.62B$10.34B
Cash & Equivalentsn/an/an/an/an/an/an/an/an/an/a$2.40B
Operating Cash Flow$3.63B$2.31B$1.82B$6.68B$5.59B$7.45B$8.11B$7.07B$6.44B$6.24B$6.66B
Capital Expenditures$952.00M$910.00M$1.18B$1.61B$1.75B$1.60B$1.50B$1.70B$1.58B$1.37B$1.42B
Free Cash Flow$2.68B$1.40B$638.00M$5.07B$3.84B$5.85B$6.61B$5.37B$4.86B$4.87B$5.24B
Share Repurchases$3.78B$3.25B$1.80B$33.00M$1.46B$2.20B$368.00M$1.41B$4.87B$2.07B$3.75B
Dividends Paid$1.60B$1.56B$1.98B$3.31B$3.37B$3.42B$3.39B$3.32B$3.19B$2.80B$2.68B
Shares Outstanding516.73M530.28M539.47M552.58M549.25M571.85M577.75M575.18M576.58M594.88M596.73M
Dividends Per Sharen/a$2.92$3.61$6.00$5.96$5.92$5.88$5.76$5.44$4.70$4.44
Weighted Average Diluted Sharesn/a541.30M552.40M553.90M567.60M585.30M582.20M585.10M602.00M612.70M618.70M
EPS (Basic)n/a$6.05$7.58-$12.63$10.21$10.23$9.43$7.83$9.09$8.13$8.35

Price chart

Chart and quotes by TradingView. Exchange coverage and delays vary.

Open chart on TradingView